Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 9OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Patient Satisfaction 1Pain 1Neoplasms 1Lymphoma, Follicular 1Hypoxia 1Colonic Neoplasms 1

Interventions

Leucovorin 4Fluorouracil 3Oxaliplatin 2Laparoscopy 2Cetuximab 2Capecitabine 2tislelizumab 1ferric maltol 1envafolimab 1Tranexamic Acid 1Surgical Procedures, Operative 1Ropivacaine 1Propofol 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Nitrous Oxide 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Motivational Interviewing 1Isoflurane 1Irinotecan 1Ipilimumab 1Immunohistochemistry 1HMPL-013 1Folfox protocol 1Filgrastim 1Fentanyl 1Epinephrine 1Endoscopic Mucosal Resection 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Colonic Neoplasms × Propofol × Clear all
NCT02326727 2014-12-29

Influence of Epidural Analgesia on Natural Killer Cell (NK) Activity After Colonic Cancer Surgery

Hillel Yaffe Medical Center

Phase NA Unknown
30 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡